ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Cushman & Wakefield Selected to Lease Life Science Facility in Phoenix

Cushman & Wakefield (NYSE: CWK) has been engaged by Wexford Science & Technology, LLC to provide leasing services for its recently constructed life science and biolab facility, 850 Phoenix Biomedical Campus (PBC), in downtown Phoenix, Arizona.

The LEED Gold-certified 850 PBC is a 227,113-square-foot (SF), seven-story Class A building located at 850 N Fifth St and situated within the larger 30-acre PBC. Completed in late 2020, the building is 65% leased to multiple tenants and anchored by Arizona State University (ASU).

The entire fifth floor of the building will also feature a market-ready lab/incubator space known as Wexford Innovation Labs. Currently under construction, the specialized space is designed as a shared work environment for life science, biotech or other industry-related users from 100 to 15,000 SF. It will be available for occupancy in the third quarter of 2022.

The Cushman & Wakefield Leasing team is led by Alexandra Loye with Scott Boardman and Kristina Cutillo. Cushman & Wakefield also provides facility management for Wexford’s local and national portfolio. Wexford is managing and leasing the Wexford Innovation Labs.

“850 PBC is an innovative project offering an opportunity for both small and large life science tenants to cultivate new relationships, collaborate and thrive,” said Loye. “Already with a strong foundation in diagnostics and medical device, Phoenix is an emerging hub for life science and biotech. Cushman & Wakefield is thrilled to have been selected to represent this project, and in helping to further advance Phoenix’s future in an important sciences-driven sector.”

Maricopa Community Colleges’ CEI LabForce program, located on the first floor, provides onsite life science workforce development training. Furthermore, the building is designed with multiple open common areas for meetings and collaboration, an activated lobby, outdoor plazas, a variety of sitting areas, local art, a stage for events and a ground floor restaurant.

Loye added, “In addition to 850 PBC, Wexford’s development on the Phoenix Biomedical Campus will offer scalability, flexibility and growth opportunities for tenants up to approximately 2 million SF when all phases of development are completed.”

About Cushman & Wakefield

Cushman & Wakefield (NYSE: CWK) is a leading global real estate services firm that delivers exceptional value for real estate occupiers and owners. Cushman & Wakefield is among the largest real estate services firms with approximately 50,000 employees in over 400 offices and 60 countries. In 2020, the firm had revenue of $7.8 billion across core services of property, facilities and project management, leasing, capital markets, valuation and other services. To learn more, visit www.cushmanwakefield.com or follow @CushWake on Twitter.

About Wexford Science & Technology

Wexford Science & Technology, LLC, is a real estate company exclusively focused on partnering with universities, academic medical centers and research companies to develop vibrant, mixed-use communities. Wexford’s communities are built on a foundation of discovery, innovation and entrepreneurial activity that creates visible outcomes in the form of substantial economic growth, new and diverse jobs, and community transformation. Wexford targets strategic opportunities with top-tier research universities that are directly on or contiguous to dense, urban campuses. Presently Wexford has developed 15 Knowledge Communities across the United States.

Cushman & Wakefield Selected to Lease Life Sciences Facility in Phoenix

Contacts

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.